Bg pattern

FOLIFERRON 100 MG / 0.150 MG FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use FOLIFERRON 100 MG / 0.150 MG FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

PACKAGE LEAFLET:INFORMATION FOR THE USER

FOLIFERRON 100 mg / 0.150 mg coated tablets

Iron fumarate / Folic acid

Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.

Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor.

  • Keep this package leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. See section 4.
  • You should consult your doctor if your condition worsens or does not improve.

Contents of the package leaflet

  1. What is Foliferron and what is it used for.
  2. What you need to know before taking Foliferron.
  3. How to take Foliferron.
  4. Possible side effects.
  5. Storage of Foliferron.
  6. Package contents and additional information

1. What is Foliferron and what is it used for

Foliferron tablets are an additional supplement of iron and folic acid (a vitamin) and are used to prevent iron and folic acid deficiencies in pregnant women, as well as to prevent certain fetal alterations.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Foliferron

Do not take Foliferron

  • If you are allergic to iron, folic acid, or any of the other components of this medication (listed in section 6).
  • If you have an excess of iron in your body (e.g., hemochromatosis, hemosiderosis).
  • If you have a vitamin B12 deficiency (megaloblastic anemia)
  • If you have undergone repeated blood transfusions
  • If you are receiving simultaneous intravenous therapy with iron.

Warnings and precautions

  • It is possible, although rare, that you may develop a hypersensitivity reaction to folic acid.
  • If you have an acute condition in your digestive system (such as gastroduodenal ulcer or colitis).
  • This medication should not be used in cases of certain types of anemia, such as megaloblastic or pernicious anemia.
  • When taking Foliferron, the stools may turn dark green or black. This effect is harmless.

Using Foliferron with other medications

Tell your doctor or pharmacist if you are using or have recently used other medications, including those purchased without a prescription.

Note that these instructions may also apply to medications that have been used before or may be used after.

Tell your doctor if:

  • you are taking barbiturates, as concurrent administration may reduce folic acid levels and the effectiveness of the barbiturate.
  • you are taking medications with cholestyramine or colestipol (medications to reduce blood cholesterol levels), as they may decrease folic acid absorption.
  • you are taking medications with sulfasalazine (used to treat inflammatory bowel diseases, such as ulcerative colitis), as the need for folic acid in these patients may increase.
  • you are epileptic and are being treated with anticonvulsants such as phenytoin and primidone, as Foliferron may increase the frequency of seizures.
  • you are taking medications with pyrimethamine (used to treat malaria), as concurrent administration with folic acid may reduce the effectiveness of pyrimethamine.
  • you are taking medications with ascorbic acid (vitamin C), as iron absorption may be altered.
  • you are being treated with proton pump inhibitors, such as pantoprazole, esomeprazole, omeprazole, or lansoprazole, as they may reduce the effect of iron salts.
  • you are being treated with medications containing acetohydroxamic acid (used to treat infectious kidney stones), as simultaneous use with iron supplements reduces the absorption of these medications.
  • you are receiving treatment with dimercaprol (a medication used as an antidote for certain substance intoxications), as concurrent administration with iron produces a toxic complex, so iron treatment should be postponed until at least 24 hours after discontinuation of dimercaprol treatment.
  • you are taking certain antibiotics, such as tetracyclines or quinolones, you should take Foliferron 2 or 3 hours before or after the antibiotic.
  • you are taking medications with thyroxine (for thyroid disorders) or penicillamine (an antirheumatic), Foliferron may decrease the effect of these medications, so you should avoid taking Foliferron 2 hours before and after administration of these medications.
  • you are taking antacids, calcium supplements, or medications containing bicarbonate, carbonate, oxalates, or phosphates, as these compounds may reduce Foliferron absorption. You should take these medications at least 2 hours after Foliferron administration.
  • you are taking medications with chloramphenicol (an antibiotic), as they may reduce folic acid absorption and decrease the effect of iron.
  • you are taking medications with methyldopa, Foliferron may reduce its hypotensive effect.
  • you are being treated with non-steroidal anti-inflammatory drugs, such as salicylates or methylbutazone, as concurrent oral administration with Foliferron may produce a reciprocal potentiation of effects due to irritation of the gastrointestinal mucosa.
  • you are being treated with oral bisphosphonates, used to treat and prevent osteoporosis, Foliferron administration should be avoided 2 hours before and after administration of these medications.

Using Foliferron with food and beverages

Certain foods, such as tea, coffee, milk, and cereals, may reduce iron absorption.

Pregnancy, breastfeeding, and fertility

Consult your doctor or pharmacist before taking any medication.

The use of Foliferron during pregnancy is safe, as pregnancy can cause iron and folic acid deficiencies, and therefore, it is recommended as a preventive measure.

The use of iron and folic acid, the two active principles of Foliferron, during breastfeeding is safe, although folic acid is excreted in breast milk. This is a physiological situation in which deficiency of the two nutrients can occur, so it is recommended as a preventive measure.

Driving and using machines

The influence of Foliferron on the ability to drive and use machines is nil or insignificant.

Foliferron contains sucrose

If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.

3. How to take Foliferron

Follow the administration instructions for Foliferron tablets exactly as indicated by your doctor. Consult your doctor or pharmacist if you have any doubts.

The recommended dose is 1 tablet 3 times a day. Take the tablet whole, with a little water or fruit juice (avoid milk), preferably after meals.

If you take more Foliferron than you should

Overdose with Foliferron is rare in adults, but it can occur in children. Toxicity due to excessive intake is related to iron overdose. If you have taken a large amount of Foliferron at once, you may experience stomach discomfort or other symptoms that require urgent attention and treatment.

In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service. Phone 915 620 420, indicating the medication and the amount used.

If you forget to take Foliferron

Remember to take your medication. If you forget to take a dose, take it as soon as possible, unless it is almost time for the next dose. Do not take a double dose to make up for forgotten doses.

If you have any other questions about the use of this product, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, Foliferron tablets can cause side effects, although not everyone experiences them.

The most common side effects (may affect up to 1 in 100 patients) are especially abdominal pain, stomach acid, nausea, vomiting, constipation, or diarrhea. It is common for stools to turn dark green or black due to iron excretion. This effect is harmless.

Rare side effects (may affect up to 1 in 1,000 patients): in rare cases, a severe allergic reaction may occur. Consult your doctor immediately if you experience any of the following symptoms: flushing, itching/swelling (especially of the face, tongue, or throat), dizziness, and/or breathing difficulties.

Reporting side effects

If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Foliferron

Keep out of sight and reach of children.

Store at room temperature.

Do not use Foliferron after the expiration date shown on the packaging, after CAD. The expiration date is the last day of the month indicated.

Medications should not be disposed of through wastewater or household waste. Deposit the packaging and unused medications in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.

6. Package contents and additional information

Composition of Foliferron tablets

  • The active ingredients are: Iron (in the form of iron fumarate) and folic acid. Each tablet contains 100 mg of iron fumarate (equivalent to 32.8 mg of iron) and 0.150 mg of folic acid.
  • The other ingredients are: sucrose, cornstarch, sodium carmellose, magnesium stearate, microcrystalline cellulose, povidone K90, cetyl alcohol, ethanol, colloidal silica, polyethylene glycol 3350, arabic gum, polyethylene glycol 6000, basic calcium phosphate, gelatin, polyvinyl acetate, Eudragit E; talc, reddish-brown iron oxide, yellow iron oxide (E-172), wax, and water.

Appearance of the product and package contents

Foliferron is brown coated tablets in packages of 30 tablets.

Marketing authorization holder and manufacturer

Teofarma S.R.L.

Via F.lli Cervi 8

27010 VALLE SALIMBENE (Pavia)

ITALY

Date of the last revision of this package leaflet: January 2018

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es

Online doctors for FOLIFERRON 100 MG / 0.150 MG FILM-COATED TABLETS

Discuss questions about FOLIFERRON 100 MG / 0.150 MG FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for FOLIFERRON 100 MG / 0.150 MG FILM-COATED TABLETS?
FOLIFERRON 100 MG / 0.150 MG FILM-COATED TABLETS does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in FOLIFERRON 100 MG / 0.150 MG FILM-COATED TABLETS?
The active ingredient in FOLIFERRON 100 MG / 0.150 MG FILM-COATED TABLETS is ferrous fumarate and folic acid. This information helps identify medicines with the same composition but different brand names.
How much does FOLIFERRON 100 MG / 0.150 MG FILM-COATED TABLETS cost in pharmacies?
The average pharmacy price for FOLIFERRON 100 MG / 0.150 MG FILM-COATED TABLETS is around 1.76 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures FOLIFERRON 100 MG / 0.150 MG FILM-COATED TABLETS?
FOLIFERRON 100 MG / 0.150 MG FILM-COATED TABLETS is manufactured by Teofarma S.R.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of FOLIFERRON 100 MG / 0.150 MG FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether FOLIFERRON 100 MG / 0.150 MG FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to FOLIFERRON 100 MG / 0.150 MG FILM-COATED TABLETS?
Other medicines with the same active substance (ferrous fumarate and folic acid) include TOTYLEM 60 MG/0.4 MG FILM-COATED TABLETS, CARBOXIMALTOSA FERRICA TEVA 50 MG/ML Injectable Dispersion and Perfusion Solution, FERACCRU 30 mg HARD CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media